Caitong International Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4K Buy
49
+33
+206% +$718 ﹤0.01% 1462
2026
Q1
$278 Buy
+16
New +$303 ﹤0.01% 1812
2025
Q4
– Sell
-11
Closed -$160 – 1935
2025
Q3
$160 Buy
+11
New +$157 ﹤0.01% 1696
2025
Q2
– Sell
-75
Closed -$1.33K – 2055
2025
Q1
$1.33K Buy
+75
New +$1.61K ﹤0.01% 1483

Other funds holding CDNA

Caitong International Asset Management's CDNA Position: Q2 2026 in Review

Caitong International Asset Management increased its CareDx (CDNA) stake by 206% in Q2 2026, buying an estimated $718 and bringing the position to 49 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Caitong International Asset Management first reported a position in CDNA in Q1 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Caitong International Asset Management held 49 shares of CareDx worth $1.4K as of Q2 2026.
  • Caitong International Asset Management bought 33 CareDx shares in Q2 2026, an estimated $718.
  • CareDx made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1462 holding.
  • Caitong International Asset Management first reported a position in CareDx in Q1 2025 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.